Back to all events
Datum
28 September 2026 09:00 – 30 September 2026 13:00
Location
The Nucleus
Tech Lane Science Park Ghent
Suzanne Tassierstraat 11
9052 Ghent, Belgium
Organized by
EUFEPS & CESPE
Event type News labels / tags
Industrial biotech
Research

EuPAT 13 & CESPE Conference 2026

EuPAT 13 & CESPE Conference 2026

Process Analytical Technology (PAT) and Quality by Design (QbD) are foundational approaches in modern pharmaceutical development, enabling data-driven process understanding, real-time control and quality assurance. The EuPAT 13 & CESPE Conference 2026 brings together researchers and professionals from across academia, industry, and regulatory bodies to explore how batch, mini-batch and continuous manufacturing platforms, combined with end-to-end integration, automation and digitalization, are shaping drug development and production.

This year’s theme is:
Intelligent, Integrated and Autonomous Pharmaceutical Manufacturing:
From Molecule to Medicine through Connected Platforms, AI and Self-Driving Technologies

Across an implementation-focused industry-led CESPE session, a hands-on workshop, and three scientific sessions, the program highlights next-generation sensors, advanced PAT tools, innovative QbD strategies and the application of artificial intelligence across the pharmaceutical lifecycle.

Day 1 (28.09.2026)
CESPE Industry-Focused Session (Morning)
PAT in Practice: Implementation Challenges, Measurable Impact and Real Outcomes
Industrial use-cases of PAT, focused on the practical challenges of implementing PAT and its sustainability dimension

EuPAT/CESPE Workshops (Afternoon)
Hands-on session showcasing the latest equipment and technologies in pharma development and manufacturing
Explore the new core facility in The Nucleus and come face-to-face with the new equipment and development teams behind it

Day 2 (29.09.2026)
EuPAT Session 1 (Morning)
Next-generation sensors, advanced PAT tools and innovative QbD strategies
Supporting real-time monitoring, intelligent control and robust, flexible manufacturing across batch, mini-batch and continuous processes

EuPAT Session 2 (Afternoon)
Integrated and autonomous pharmaceutical platforms
Connecting drug substance and drug product development through end-to-end manufacturing

Day 3 (30.09.2026)
EuPAT Session 3 (Morning)
Artificial intelligence across the pharmaceutical lifecycle
Enabling predictive modeling, data-driven decision making and autonomous operation’s

For detailed information please see our Conference Brochure (link) and Programme Webpage (link).

Upcoming events

-
Medical Device Seminar Series 2026 – The EU Medical Device Regulation in Motion: Regulators, Industry and the Road Ahead